Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease

被引:122
作者
Galasko, D
Clark, C
Chang, L
Miller, B
Green, RC
Motter, R
Seubert, P
机构
[1] UNIV CALIF SAN DIEGO,DEPT NEUROSCI NEUROL,SAN DIEGO,CA 92103
[2] UNIV PENN,MED CTR,DEPT NEUROL,PHILADELPHIA,PA 19104
[3] UNIV CALIF LOS ANGELES,DEPT NEUROL,LOS ANGELES,CA 90024
[4] EMORY UNIV,DEPT NEUROL,ATLANTA,GA 30322
[5] ATHENA NEUROSCI INC,SAN FRANCISCO,CA
关键词
D O I
10.1212/WNL.48.3.632
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
CSF levels of tau protein are increased in many patients with Alzheimer's disease (AD), Studies disagree on whether the increase is found in moderate or severe AD to a greater extent than in mild AD, and in two reports there was an inverse correlation between tau levels and cognitive scores, To readdress this question, we measured CSF tau in a group of mildly impaired patients with AD (Mini-Mental State Examination [MMSE] scores greater than or equal to 20/30) and compared their tau levels with those in age-comparable normal and neurologic controls, We found that the mean level of CSF tau was significantly increased in the AD group compared with the controls, and 29 of 36 patients with AD had levels that exceeded a cutoff determined in a previous study, CSF tau levels did not correlate with MMSE scores, These findings and those of previous studies show that elevated CSF tau levels are found in most patients with AD, occur early in the course of dementia, and may be useful in supporting the diagnosis of AD.
引用
收藏
页码:632 / 635
页数:4
相关论文
共 19 条
[1]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[2]   tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease? [J].
Blennow, K ;
Wallin, A ;
Agren, H ;
Spenger, C ;
Siegfried, J ;
Vanmechelen, E .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) :231-245
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]   CLINICAL-NEUROPATHOLOGICAL CORRELATIONS IN ALZHEIMERS-DISEASE AND RELATED DEMENTIAS [J].
GALASKO, D ;
HANSEN, LA ;
KATZMAN, R ;
WIEDERHOLT, W ;
MASLIAH, E ;
TERRY, R ;
HILL, R ;
LESSIN, P ;
THAL, LJ .
ARCHIVES OF NEUROLOGY, 1994, 51 (09) :888-895
[5]   PROGRESSIVE SUPRANUCLEAR PALSY - NEUROPATHOLOGIC AND CLINICAL HETEROGENEITY [J].
GEARING, M ;
OLSON, DA ;
WATTS, RL ;
MIRRA, SS .
NEUROLOGY, 1994, 44 (06) :1015-1024
[6]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .10. NEUROPATHOLOGY CONFIRMATION OF THE CLINICAL-DIAGNOSIS OF ALZHEIMERS-DISEASE [J].
GEARING, M ;
MIRRA, SS ;
HEDREEN, JC ;
SUMI, SM ;
HANSEN, LA ;
HEYMAN, A .
NEUROLOGY, 1995, 45 (03) :461-466
[7]   INCREASED LEVELS OF TAU-PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE - CORRELATION WITH DEGREE OF COGNITIVE IMPAIRMENT [J].
HOCK, C ;
GOLOMBOWSKI, S ;
NASER, W ;
MULLERSPAHN, F .
ANNALS OF NEUROLOGY, 1995, 37 (03) :414-415
[8]   INCREASED CEREBROSPINAL-FLUID TAU IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
JENSEN, M ;
BASUN, H ;
LANNFELT, L .
NEUROSCIENCE LETTERS, 1995, 186 (2-3) :189-191
[9]   Incorrect diagnosis of Alzheimer's disease a clinicopathologic study [J].
Klatka, LA ;
Schiffer, RB ;
Powers, JM ;
Kazee, AM .
ARCHIVES OF NEUROLOGY, 1996, 53 (01) :35-42
[10]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939